HU9702039D0 - Estrogen agonist/antagonists treatment of atheroscerosis - Google Patents
Estrogen agonist/antagonists treatment of atheroscerosisInfo
- Publication number
- HU9702039D0 HU9702039D0 HU9702039A HUP9702039A HU9702039D0 HU 9702039 D0 HU9702039 D0 HU 9702039D0 HU 9702039 A HU9702039 A HU 9702039A HU P9702039 A HUP9702039 A HU P9702039A HU 9702039 D0 HU9702039 D0 HU 9702039D0
- Authority
- HU
- Hungary
- Prior art keywords
- atheroscerosis
- estrogen agonist
- antagonists treatment
- antagonists
- treatment
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3127596P | 1996-11-15 | 1996-11-15 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9702039D0 true HU9702039D0 (en) | 1998-01-28 |
HUP9702039A2 HUP9702039A2 (hu) | 1999-06-28 |
HUP9702039A3 HUP9702039A3 (en) | 1999-07-28 |
Family
ID=21858562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702039A HUP9702039A3 (en) | 1996-11-15 | 1997-11-14 | Use of estrogen agonist/antagonists for the production of medicaments against atherosclerosis |
Country Status (11)
Country | Link |
---|---|
US (2) | US6069175A (hu) |
EP (1) | EP0843999A1 (hu) |
JP (1) | JPH10147522A (hu) |
KR (1) | KR19980042434A (hu) |
AU (1) | AU735617B2 (hu) |
CA (1) | CA2221091C (hu) |
HU (1) | HUP9702039A3 (hu) |
IL (1) | IL122124A (hu) |
MY (1) | MY117009A (hu) |
NZ (1) | NZ329188A (hu) |
ZA (1) | ZA9710295B (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR008155A1 (es) * | 1996-09-06 | 1999-12-09 | Smithkline Beecham Corp | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. |
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6353003B1 (en) | 1998-06-17 | 2002-03-05 | Eli Lilly And Company | Method for reducing levels of homocysteine and C-reactive protein |
GB9827121D0 (en) * | 1998-12-09 | 1999-02-03 | Orion Corp | Agent for lowering endothelin levels |
CO5170459A1 (es) * | 1999-06-01 | 2002-06-27 | Pfizer Prod Inc | Terapia transdermica con agonistas-antagonistas de estrogenos len-ol, administrados mediante medios transdermicos |
TWI303990B (en) * | 2000-10-17 | 2008-12-11 | Pfizer Prod Inc | New use of estrogen agonists/antagonists for improving vascular health |
WO2002047723A1 (fr) * | 2000-12-11 | 2002-06-20 | Takeda Chemical Industries, Ltd. | Compositions medicamenteuses presentant une meilleure hydrosolubilite |
AU781168B2 (en) * | 2001-01-26 | 2005-05-12 | Pfizer Products Inc. | Method of treating certain cancers using an estrogen agonist/antagonist |
ITRM20010695A1 (it) * | 2001-11-26 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Uso della propionil l-carnitina o di un suo sale farmacologicamente accettabile per la preparazione di un medicamento per il trattamento del |
US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
US20050119324A1 (en) * | 2003-09-24 | 2005-06-02 | Wyeth | Methods of treating atherosclerosis using NF-kB inhibitors |
JP6273902B2 (ja) * | 2014-02-28 | 2018-02-07 | 日立化成株式会社 | 二次電池 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3046719C2 (de) * | 1980-12-11 | 1983-02-17 | Klinge Pharma GmbH, 8000 München | 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel |
JPH04312526A (ja) * | 1991-04-09 | 1992-11-04 | Fujisawa Pharmaceut Co Ltd | 骨疾患治療剤 |
US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US6197789B1 (en) * | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
DE4320898A1 (de) * | 1993-06-24 | 1995-01-05 | Denecke Rainer Dr Med Vet | Präparat zur Therapie und Prophylaxe von Erkrankungen, die bei Imbalancen von Plasmalipiden auftreten |
US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
ES2163425T3 (es) * | 1993-12-21 | 2002-02-01 | Lilly Co Eli | Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica. |
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
US5478847A (en) * | 1994-03-02 | 1995-12-26 | Eli Lilly And Company | Methods of use for inhibiting bone loss and lowering serum cholesterol |
US5426123A (en) * | 1994-05-11 | 1995-06-20 | Eli Lilly And Company | Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives |
US5441986A (en) * | 1994-07-19 | 1995-08-15 | Pfizer Inc. | Estrogen agonists as remedies for prostate and cardiovascular diseases |
US7501441B1 (en) * | 1994-09-20 | 2009-03-10 | Eli Lilly And Company | Naphthyl compounds, intermediates, processes, compositions, and methods |
HUP9800521A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or propylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis |
-
1997
- 1997-10-21 US US08/955,062 patent/US6069175A/en not_active Expired - Fee Related
- 1997-11-03 EP EP97308797A patent/EP0843999A1/en not_active Withdrawn
- 1997-11-06 IL IL12212497A patent/IL122124A/en not_active IP Right Cessation
- 1997-11-12 JP JP9310577A patent/JPH10147522A/ja active Pending
- 1997-11-13 MY MYPI97005443A patent/MY117009A/en unknown
- 1997-11-13 CA CA002221091A patent/CA2221091C/en not_active Expired - Fee Related
- 1997-11-14 AU AU45185/97A patent/AU735617B2/en not_active Ceased
- 1997-11-14 ZA ZA9710295A patent/ZA9710295B/xx unknown
- 1997-11-14 HU HU9702039A patent/HUP9702039A3/hu unknown
- 1997-11-14 KR KR1019970060005A patent/KR19980042434A/ko not_active Application Discontinuation
- 1997-11-14 NZ NZ329188A patent/NZ329188A/xx unknown
-
1999
- 1999-09-28 US US09/407,190 patent/US6124346A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH10147522A (ja) | 1998-06-02 |
HUP9702039A3 (en) | 1999-07-28 |
AU735617B2 (en) | 2001-07-12 |
NZ329188A (en) | 2000-08-25 |
EP0843999A1 (en) | 1998-05-27 |
AU4518597A (en) | 1998-05-21 |
ZA9710295B (en) | 1999-05-14 |
IL122124A (en) | 2002-11-10 |
US6124346A (en) | 2000-09-26 |
CA2221091A1 (en) | 1998-05-15 |
KR19980042434A (ko) | 1998-08-17 |
MY117009A (en) | 2004-04-30 |
IL122124A0 (en) | 1998-04-05 |
US6069175A (en) | 2000-05-30 |
HUP9702039A2 (hu) | 1999-06-28 |
CA2221091C (en) | 2002-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23913A (en) | Estrogen agonists / antagonists | |
PL330850A1 (en) | Antagonists of il-8 receptors | |
PL330849A1 (en) | Antagonists of il-8 receptors | |
PL331539A1 (en) | Antagonists of il-8 receptor | |
ZA971709B (en) | Method of increasing testosterone | |
SI0736525T1 (en) | Benzonitriles as 5-HT agonists and antagonists | |
PL341114A1 (en) | Antagonists of thrombosin receptors | |
HU9702039D0 (en) | Estrogen agonist/antagonists treatment of atheroscerosis | |
PL328633A1 (en) | Oxazolic and thiadizolic antagonists of muscarinic receptors | |
PL330195A1 (en) | Antagonist of dopamine d4 receptor | |
HU9702480D0 (en) | New polymorphe modification of doxazosin-mesylate | |
PL320638A1 (en) | Antagonists of endothein receptors | |
ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin | |
HU9702479D0 (en) | New polymorphe modification of doxazosin-mesylate | |
PL334186A1 (en) | Derivatives of cyclopeptides | |
PL320529A1 (en) | Apparatus for combined drilling of blast-holes and anchor-holes | |
AU1794397A (en) | Use of alpha1-adrenoceptor antagonists | |
TW315749U (en) | Improved structure of rocket-launching device | |
ZA971483B (en) | Pure somatostatin antagonist and methods for use thereof | |
TW346938U (en) | Improved structure for rectifier of outlet-head | |
HU1001U (en) | Set of device | |
EG21458A (en) | Lavatory apparatus | |
TW323491U (en) | Improved structure of tea-making device | |
TW318439U (en) | Improved structure of circle-drawing device | |
TW298992U (en) | Improved structure of slurry-spraying device |